Peramivir
Top View
- Therapeutic Class Overview Antivirals, Influenza
- Potential Drug-Drug Interactions of Antiretrovirals and Antimicrobials
- Antivirals Targeting the Surface Glycoproteins of Influenza Virus
- Pandemic H1N1 'Swine Flu'
- USP Medicare Model Guidelines V7.0 (With Example Part D Drugs)
- 2019 Peramivir for Influenza a and B Viral Infections
- Antivirals, Influenza
- An HHS Retrospective on the 2009 H1N1 Influenza Pandemic to Advance All Hazards Preparedness
- Antivirals, Influenza
- Review Laninamivir and Its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of Influenza
- Assessment of Adverse Events Related to Anti-Influenza Neuraminidase
- Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis
- (H1N1) 2009 and Other Influenza Viruses
- Assessment of Evidence for COVID-19-Related Treatments
- Alpivab, INN-Peramivir
- Influenza Antiviral Medications: Summary for Clinicians
- RAPIVAB Safely and Effectively
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal